Gene Therapeutic Strategies for Peripheral Artery Disease and New Opportunities Provided by Adeno-Associated Virus Vectors

LM Khachigian, RL Varcoe, T Suoranta… - … and Vascular Biology, 2023 - Am Heart Assoc
Peripheral artery disease (PAD) is a vascular disorder caused by occlusive atherosclerosis,
which commonly impairs blood flow to the lower extremities. The prevalence of PAD is …

Therapeutic angiogenesis: recent and future prospects of gene therapy in peripheral artery disease

M Tanaka, K Taketomi, Y Yonemitsu - Current Gene Therapy, 2014 - ingentaconnect.com
Peripheral artery disease (PAD) is a highly prevalent disease, which still has unmet medical
needs. Therapeutic angiogenesis for PAD, achieved by gene therapy, has achieved …

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral …

S Rajagopalan, ER Mohler III, RJ Lederman… - Circulation, 2003 - Am Heart Assoc
Background—“Therapeutic angiogenesis” seeks to improve perfusion by the growth of new
blood vessels. The Regional Angiogenesis with Vascular Endothelial growth factor (RAVE) …

Regenerative therapy in peripheral artery disease

A Germani, C Di Campli, G Pompilio… - Cardiovascular …, 2009 - Wiley Online Library
Patients with peripheral artery disease (PAD) and critical limb ischemia are the main
candidates for limb amputations and have a poor life expectancy. Frequently, these patients …

Interventions for lower extremity peripheral artery disease

JS Hiramoto, M Teraa, GJ de Borst… - Nature Reviews …, 2018 - nature.com
Peripheral artery disease (PAD) of the lower extremities is a common manifestation of
atherosclerosis that is increasing in global prevalence and in the associated public health …

Gene therapy in the treatment of peripheral arterial disease

NA Mughal, DA Russell, S Ponnambalam… - Journal of British …, 2012 - academic.oup.com
Background Peripheral arterial disease remains a significant global health burden despite
revolutionary improvements in endovascular techniques over the past decade. The …

[HTML][HTML] Gene therapy for peripheral arterial disease

R Forster, A Liew, V Bhattacharya, J Shaw… - … of systematic reviews, 2018 - ncbi.nlm.nih.gov
Background Peripheral arterial disease (PAD), caused by narrowing of the arteries in the
limbs, is increasing in incidence and prevalence as our population is ageing and as …

Vascular regeneration in ischemic Hindlimb by adeno‐associated virus expressing conditionally silenced vascular endothelial growth factor

J Boden, RM Lassance‐Soares, H Wang… - Journal of the …, 2016 - Am Heart Assoc
Background Critical limb ischemia (CLI) is the extreme manifestation of peripheral artery
disease, a major unmet clinical need for which lower limb amputation is the only option for …

[HTML][HTML] Gene-therapeutic strategies targeting angiogenesis in peripheral artery disease

F Sanada, Y Taniyama, J Muratsu, R Otsu, H Shimizu… - Medicines, 2018 - mdpi.com
The World Health Organization announced that cardiovascular disease is the number one
cause of death globally, representing 31% of all global deaths. Coronary artery disease …

Gene therapy for therapeutic angiogenesis in peripheral arterial disease-a systematic review and meta-analysis of randomized, controlled trials

A Hammer, S Steiner - Vasa, 2013 - econtent.hogrefe.com
Background: Beyond pharmacological, endovascular and surgical treatment strategies for
peripheral arterial disease (PAD), therapeutic angiogenesis has been advocated to relieve …